4//SEC Filing
GENOCEA BIOSCIENCES, INC. 4
Accession 0000904454-15-000509
CIK 0001457612operating
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:17 PM ET
Size
10.4 KB
Accession
0000904454-15-000509
Insider Transaction Report
Form 4
HETHERINGTON SETH V
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2015-08-07$2.02/sh+2,011$4,062→ 16,000 total - Exercise/Conversion
Common Stock
2015-08-07$2.02/sh+2,989$6,038→ 13,989 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-08-07−2,989→ 11,562 totalExercise: $2.02Exp: 2021-02-17→ Common Stock (2,989 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2015-08-07−2,011→ 71,955 totalExercise: $2.02Exp: 2021-02-17→ Common Stock (2,011 underlying)
Footnotes (1)
- [F1]The option was granted on 2/17/2011 and the vesting schedule was completed in February 2015.
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001457612
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:17 PM ET
- Size
- 10.4 KB